CAMARO, RCT MMF Vs Aza to induce remission. Higher remission in MMF, similar AE rates, ⬆️ discontinuations in AZA group. Nausea most common reason for discontinuation. Great data - will it change practice/guidelines? Effective contraception if appropriate a must #EASLCongress
What are the real-world practice patterns on the use of terlipressin in patients with cirrhosis and acute kidney injury? Results from the ICA-GLOBAL AKI study will be presented at #EASLCongress ! Register now: bit.ly/3UhxA5W
Had good opportunity to present our short course terlipressin trial in AVB🩸at #EASLCongress . Also presented poster on further decompensation after AVB.
Thanks to team lead by Shalimar for all the guidance AIIMS, New Delhi abhinav anand Sagnik Biswas Anshuman Elhence
EASLnews
Grateful to have chaired an important session this morning at #EASLCongress with passionate colleagues who shared knowledge on supporting Nutrition Impact Symptoms to Optimise Nutrition in liver disease. Your pt can not eat if they have barriers which are not managed first!
✅Preliminary data on impact of PEs exposure on the progression of PLD cysts
👉🏼confirmation needed
Thank you to my colleagues
Antonio Ciaccio 🧠 of this project
Martina Manna our fantastic datamanager 👩🏻💻
Thank you to our ❤️ PLD patients #EASLcongress HSG Gastro
Cure #fibrosis ? Say no more! Very proud to present this work on antifibrotic effect of cyclophilin inhibition at #EASLCongress ! Thanks to EASLnews EASL Education for the YI bursary that enabled me to be there in person!
ElePalma Chokshi Lab London Urbani Lab Sara Campinoti #LiverTwitter
It’s day 2 of #EASLCongress and poster day! If you’re interested in learning more about sarcopenia in end-stage liver disease please come by poster 370 during todays poster sessions!
Annalisa Berzigotti presents data on a meta-analysis on post-banding ulcer bleeding. High mortality ~22%! Well done Maria Brito, Matthias Knecht, jaumebosch and Reiner Wiest!! #EASLCongress Universität Bern Insel Gruppe
Exciting presentation at #EASL2023 !
Our #IPD #metaanalysis on #SpleenStiffnessMeasurament on CSPH diagnosis is now accepted in The Lancet Gastroenterology & Hepatology 🔜
✅ @BavenoVII➕SSM can identify patients should be treated with #NSBB
#LiverTwitter #EASLCongress
Happy to present at #EASLcongress #EASL2023 the interim results on our study on 100 Hz #spleen #stiffness measurement in a multi-center cohort of biopsied #NAFLD patients for the detection of advanced #fibrosis ! Great perspectives!! Luca Miele Jörn Schattenberg Manuel Romero-Gómez
Come during the lunch break to speak with our Naomi Lange about her work on screening for advanced disease in NAFLD and T2DM! 👏🏽 #EASLCongress #livertwitter EASLnews
#EASLCongress - 2023
Our resident Deepankshi presenting her work on 'Intermittent Fasting in NAFLD' in oral session at #EASLCongress
Encouraging conclusions.
#LiverTwitter #NCDs
EASL Education EASLnews AASLD Thomas Berg Aleksander Krag Francesco Paolo Russo Jeffrey V. Lazarus
Hepatology PGI
Dr Felicity Williams presenting at #EASLcongress 2023 #ILC2023 on physical frailty in #livertransplant University Hospitals Birmingham @NIHRBhamBRC Birmingham HPB & Liver Transplant Unit [email protected] LiverAHPs Leading the way for physiotherapy in severe liver diseases
Excited to present at #EASLCongress in Vienna on possible impacts of CDC Hepatitis's draft guidelines for early RNA testing to identify perinatal HCV. Thanks to Andrea Ciaranello, MD, MPH Benjamin P. Linas Rachel Epstein, MD CHERISH MGH Medical Practice Evaluation Center (MPEC) BU-CHART